These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12043133)

  • 1. The heroin addict! A personal view.
    Cyngler C
    Aust Fam Physician; 2002 Apr; 31(4):371-3. PubMed ID: 12043133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse treatment as a strategy to prevent human immunodeficiency virus infection among intravenous drug users. How can we maximize prevention of infection?
    West AP
    Arch Intern Med; 1991 Aug; 151(8):1493-6. PubMed ID: 1651688
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Privileging pleasure: temazepam injection in a heroin marketplace.
    Dwyer R
    Int J Drug Policy; 2008 Oct; 19(5):367-74. PubMed ID: 17997090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
    Kelley MS; Chitwood DD
    Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
    J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
    Day C; White B; Ross J; Dolan K
    Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
    [No Abstract]   [Full Text] [Related]  

  • 11. More panic in needle park.
    Gossop M
    Addiction; 2005 Jul; 100(7):922-3; discussion 930-2. PubMed ID: 15955001
    [No Abstract]   [Full Text] [Related]  

  • 12. Compulsory detoxification is a major challenge to harm reduction in China.
    Larney S; Dolan K
    Int J Drug Policy; 2010 May; 21(3):165-6. PubMed ID: 19505815
    [No Abstract]   [Full Text] [Related]  

  • 13. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological trauma and PTSD symptoms as predictors of substance dependence treatment outcomes.
    Ford JD; Hawke J; Alessi S; Ledgerwood D; Petry N
    Behav Res Ther; 2007 Oct; 45(10):2417-31. PubMed ID: 17531193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Process evaluation of an out-patient detoxification service.
    Sannibale C; Fucito L; O'Connor D; Curry K
    Drug Alcohol Rev; 2005 Nov; 24(6):475-81. PubMed ID: 16361203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 17. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada.
    Cruz MF; Patra J; Fischer B; Rehm J; Kalousek K
    Int J Drug Policy; 2007 Jan; 18(1):54-61. PubMed ID: 17689344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to treatment of depression in active injection drug users: the minerva study.
    Stein MD; Herman DS; Solomon DA; Anthony JL; Anderson BJ; Ramsey SE; Miller IW
    J Subst Abuse Treat; 2004 Mar; 26(2):87-93. PubMed ID: 15050085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM; Faggiano F; Amato L; Salamina G; Davoli M; Mathis F; Cuomo L; Schifano P; Burroni P; Perucci CA;
    Subst Use Misuse; 2006; 41(14):1861-79. PubMed ID: 17162594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.